"Advanced Liver Therapies at Baylor College of Medicine is a clinical research center dedicated exclusively to the development of new diagnostic tests and therapies for adults with liver diseases."

During the past decade, St. Luke's Advanced Liver Therapies conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 5 clinical trials were completed, i.e. on average, 500% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "St. Luke's Advanced Liver Therapies" #1 sponsor was "Axcella Health, Inc" with 1 trials, followed by "Gilead Sciences" with 1 trials sponsored, "Mallinckrodt" with 1 trials sponsored, "Mirum Pharmaceuticals, Inc." with 1 trials sponsored and "Tarek Hassanein" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "St. Luke's Advanced Liver Therapies" #1 collaborator was "Shanghai Sundise Traditional Chinese Medicine Co., Ltd." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "St. Luke's Advanced Liver Therapies" are "Autoimmune Hepatitis" (1 trials), "Chronic Hepatitis B" (1 trials), "Chronic Hepatitis C Infection" (1 trials), "Hepatic Encephalopathy" (1 trials) and "Hepatitis C, Chronic" (1 trials). Many other conditions were trialed in "St. Luke's Advanced Liver Therapies" in a lesser frequency.

Most popular intervention types in "St. Luke's Advanced Liver Therapies" are "Drug" (7 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "AXA1665" (1 trials), "Azathioprine" (1 trials), "Fuzheng Huayu" (1 trials) and "LCP-Tacro (tacrolimus)" (1 trials). Other intervention names were less common.

The vast majority of trials in "St. Luke's Advanced Liver Therapies" are 7 trials for "All" genders.

Currently, there are NaN active trials in "St. Luke's Advanced Liver Therapies". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in St. Luke's Advanced Liver Therapies, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in St. Luke's Advanced Liver Therapies, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".